Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.

January 31, 2024 US FDA warns consumers over copycats of Bausch + Lomb eye drops The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that ...

Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...

Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an ...

Eye health company Bausch & Lomb is recalling some of its intraocular lenses over possible safety concerns. The voluntary recall comes after the company “received reports of complications ...

Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction to a voluntary recall of several brands of its enVista line of ...

VAUGHAN, Ontario, March 17, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better ...